摘要
目的观察自身腹水超滤浓缩腹腔和静脉回输腹腔和静脉治疗肝硬化腹水疗效。方法选取笔者所在医院收治的肝硬化腹水患者32例,随机分为Ⅰ组腹水超滤浓缩回输腹腔组,Ⅱ组腹水超滤浓缩回输静脉组。观察治疗后2周及4周24h尿量、血白蛋白、尿素氮、肌酐、不良反应及腹水减少百分比。结果治疗后2周,Ⅱ组患者24h尿量、血白蛋白、不良反应百分比较Ⅰ组患者显著增高,尿素氮较Ⅰ组患者显著下降(P<0.05);两组肌酐、不良反应比较,差异无统计学意义(P>0.05)。治疗后4周,Ⅱ组患者血白蛋白较Ⅰ组患者显著增高(P<0.05)。结论腹水超滤浓缩回输腹腔和静脉治疗效果差异无统计学意义,临床可根据患者不同情况选择应用。
Objective To study the clinical efficacy of reinfusion of concentrated ascites into abdominal cavity or vein. Methods 32 patients were divided into two groups. ALB,BUN,Cr,side effects,average amount of urine in 24 hours,change of ascites were recorded. Results After two weeks therapy,BUN reduced in Ⅱ group significantly than in I group,other indexs were increased significantly in Ⅱ group（P 〈 0.05）,except BUN and side effects. After four weeks therapy,only ALB increased in Ⅱgroup significantly than in Ⅰ group（P 〈 0.05）. Conclusion There were no significant differenct in reinfusion of concentrated ascites into abdominal cavity or vein. Which method was selected should determined by the fact of patients.
出处
《中国医药科学》
2012年第3期66-67,共2页
China Medicine And Pharmacy
关键词
肝硬化
腹水
超滤浓缩
回输
Liver cirrhosis
Ascites
Concentrated
Reinfusion
